Malaysian Genomics Resource (0155) — Cash Flow Reinvestment Rate
Malaysian Genomics Resource (0155) has a Cash Flow Reinvestment Rate of 0.06x as of March 2026, reinvesting RM6.00K (capex RM6.00K ) from operating cash flow of RM98.00K. Check 0155 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Malaysian Genomics Resource Cash Flow Reinvestment Rate (2015–2026)
Historical reinvestment intensity for Malaysian Genomics Resource across 6 annual periods. Explore 0155 debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Malaysian Genomics Resource (2015–2026)
Year-by-year capital reinvestment analysis for Malaysian Genomics Resource. For live market cap and broader valuation context, see Malaysian Genomics Resource (0155) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.06x | RM71.64K | RM1.10 Million | RM71.64K | ▼ -99.9% |
| 2022 | 66.19x | RM3.77 Million | RM56.92K | RM1.33 Million | ▲ +2350.0% |
| 2020 | 2.70x | RM31.52 Million | RM11.67 Million | RM351.18K | ▼ -15.3% |
| 2017 | 3.19x | RM11.72 Million | RM3.67 Million | RM143.49K | ▲ +4571.4% |
| 2016 | 0.07x | RM251.52K | RM3.68 Million | RM181.42K | ▼ -91.5% |
| 2015 | 0.80x | RM318.34K | RM395.83K | RM318.34K | — |